Mizoribine

Mizoribine
Mizoribine
Systematic (IUPAC) name
5-hydroxy-1-β-D-ribofuranosyl-1H-imidazole-4-carboxamide
Clinical data
AHFS/Drugs.com International Drug Names
Pregnancy cat.  ?
Legal status ℞ Prescription only
Routes Oral
Identifiers
CAS number 50924-49-7
ATC code None
PubChem CID 104762
UNII 4JR41A10VP YesY
KEGG D01392 YesY
Synonyms 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxyimidazole-4-carboxamide
Chemical data
Formula C9H13N3O6 
Mol. mass 259.21 g/mol
SMILES eMolecules & PubChem
 YesY(what is this?)  (verify)

Mizoribine (INN, trade name Bredinin) is an immunosuppresive drug. The compound was first observed in Tokyo, Japan, in 1971.[1] It is a natural product, first isolated from the mould Eupenicillium brefeldianum.

References

  1. ^ Hiroaki Ishikawa (1999). "Mizoribine and Mycophenolate Mofetil". Current Medicinal Chemistry (Bentham Science): 575–597. PMID 10390602. 


v · d · eImmunomodulators: Immunosuppressive drugs / Immunosuppressants (L04)
Intracellular
(initiation)

purine synthesis inhibitors: Azathioprine • Mycophenolic acid

pyrimidine synthesis inhibitors: Leflunomide • Teriflunomide

antifolate: Methotrexate
Macrolides/
other IL-2 inhibitors
TNF-α inhibitor
Intracellular
(reception)
Sirolimus • Deforolimus • Everolimus • Temsirolimus • Zotarolimus • Biolimus A9
Extracellular
Serum target
(noncellular)
Cellular target
Unsorted
-cept (Fusion)

M: LMC

cell/phys/auag/auab/comp, igrc

imdf/ipig/hyps/tumr

proc, drug(L3/4)


Stub icon This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.